Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
5.06
+0.06 (1.20%)
Nov 20, 2024, 4:00 PM EST - Market closed
Pluri Employees
As of June 30, 2024, Pluri had 118 total employees, including 106 full-time and 12 part-time employees. The number of employees decreased by 16 or -11.94% compared to the previous year.
Employees
118
Change (1Y)
-16
Growth (1Y)
-11.94%
Revenue / Employee
$5,068
Profits / Employee
-$184,822
Market Cap
28.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nortech Systems | 775 |
ImmuCell | 79 |
DURECT | 58 |
SAB Biotherapeutics | 57 |
Surrozen | 42 |
MiNK Therapeutics | 31 |
Daré Bioscience | 26 |
OneMedNet | 20 |
PLUR News
- 8 days ago - Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 10 days ago - BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing - PRNewsWire
- 4 months ago - Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates - GlobeNewsWire
- 5 months ago - Pluri: Biotech Play With Several Opportunities Across Different Sectors - Seeking Alpha
- 5 months ago - Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges - GlobeNewsWire
- 6 months ago - U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract - GlobeNewsWire
- 6 months ago - Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale - GlobeNewsWire
- 7 months ago - Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment - GlobeNewsWire